Stocktoria
MYRIAD GENETICS INC MYGN
MYRIAD GENETICS INC financials (annual)
Bars are annual figures from 2017 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $824.5M | $837.6M | $753.2M | $678.4M | $690.6M | $557.1M | $638.6M | $851.1M | $743.7M | $771.4M |
| Gross profit | $576.6M | $585.4M | $517.0M | $476.4M | — | — | — | — | — | — |
| R&D expense | $106.8M | $113.4M | $88.7M | $85.4M | $81.9M | $73.3M | $77.2M | $85.9M | $70.8M | $74.4M |
| SG&A expense | — | — | $572.9M | $514.7M | $537.8M | $496.9M | $507.3M | $556.6M | $435.0M | $439.9M |
| Operating income | -$387.2M | -$123.5M | -$257.4M | -$140.6M | -$190.5M | -$289.7M | -$231.7M | $7.6M | $121.9M | $44.0M |
| Interest expense | — | — | $2.9M | $3.2M | $6.6M | $11.2M | $10.8M | $12.0M | $3.2M | $6.0M |
| Income tax | -$29.2M | $3.8M | $1.1M | -$28.6M | -$29.9M | -$59.9M | -$23.7M | -$4.4M | -$13.0M | $19.0M |
| Net income | -$365.9M | -$127.3M | -$263.3M | -$112.0M | -$27.2M | -$223.6M | -$199.5M | $4.6M | $133.3M | $17.4M |
| EPS (diluted) | $-3.95 | $-1.41 | $-3.18 | $-1.39 | $-0.35 | $-2.99 | $-2.69 | $0.06 | $1.85 | $0.25 |
| Operating cash flow | $1.8M | -$8.7M | -$110.9M | -$106.3M | $18.6M | — | $60.7M | $83.7M | $115.9M | $106.2M |
| Cash & equivalents | $149.6M | $102.4M | $132.1M | $56.9M | $257.4M | $117.0M | $163.7M | $93.2M | $110.9M | $102.4M |
| Inventory | $30.6M | $27.5M | $22.0M | $20.1M | $15.3M | $27.1M | $29.1M | $31.4M | $34.3M | $42.2M |
| Total assets | $706.6M | $1.0B | $1.1B | $1.2B | $1.3B | $1.4B | $1.4B | $1.6B | $1.2B | $1.2B |
| Total liabilities | $338.6M | $326.5M | $363.3M | $312.9M | $352.9M | $537.8M | $486.4M | $473.8M | $209.2M | $440.9M |
| Shareholders' equity | $368.0M | $701.1M | $783.2M | $885.8M | $967.8M | $881.0M | $918.2M | $1.1B | $966.1M | $768.4M |
Growth · year-over-year · Revenue CAGR 0.7%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue growth | -1.6% | +11.2% | +11.0% | -1.8% | +24.0% | -12.8% | -25.0% | +14.4% | -3.6% | +2.3% |
| Net income growth | — | — | — | — | — | — | -4437.0% | -96.5% | +666.1% | -85.2% |
| EPS growth | — | — | — | — | — | — | -4583.3% | -96.8% | +640.0% | -84.4% |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.